Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021)
Dentsply Sirona's (XRAY) quarterly Current Deferred Revenue came in at $68.0 million in Q4 2021, up 28.3% on a YoY basis from $53.0 million in Q4 2020, and up 28.3% quarter-over-quarter from $53.0 million in Q4 2020.
Powered by 
Analysis
Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021) Analysis & Trends
Dentsply Sirona (XRAY) has reported Current Deferred Revenue for 4 consecutive years, with $68.0 million the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Current Deferred Revenue rose 28.3% year-over-year to $68.0 million; the trailing twelve-month figure through Dec 2021 stood at $68.0 million (up 28.3% YoY), and the FY2021 full-year result was $68.0 million, up 28.3% from the prior year.
- Current Deferred Revenue improved to $68.0 million in Q4 2021 per XRAY's latest filing, from $53.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $68.0 million in Q4 2021 and bottomed at $53.0 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Align Technology | 10.78 Bn | 9.68 Bn | 757.43 Mn |
| 2 | Envista Holdings | 4.18 Bn | 3.05 Bn | 407.00 Mn |
| 3 | Dentsply Sirona | 2.10 Bn | 1.86 Bn | 493.00 Mn |
| 4 | Milestone Scientific | 36.06 Mn | 33.45 Mn | 1.56 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - |
| 6 | Vivos Therapeutics | 3.21 Mn | 1.41 Mn | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 68.00 Mn |
| Dec 31, 2020 | 53.00 Mn |
| Dec 31, 2010 | 5.66 Mn |
| Dec 31, 2009 | 3.39 Mn |